M. Ferro

574 total citations
23 papers, 439 citations indexed

About

M. Ferro is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, M. Ferro has authored 23 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in M. Ferro's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Bladder and Urothelial Cancer Treatments (3 papers). M. Ferro is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Bladder and Urothelial Cancer Treatments (3 papers). M. Ferro collaborates with scholars based in United Kingdom, Italy and Portugal. M. Ferro's co-authors include Patrick J. Smith, José M. Ferro, M.J. Rosas, Mário G. Lopes, J. B. M. ROBERTS, M O Symes, David Gillatt, A Vitali, P. Puppó and Massimo Perachino and has published in prestigious journals such as The Journal of Urology, European Urology and Urology.

In The Last Decade

M. Ferro

22 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ferro United Kingdom 9 203 132 85 68 68 23 439
Benjamin Namdarian Australia 12 218 1.1× 41 0.3× 75 0.9× 54 0.8× 4 0.1× 23 400
Hirohiko Nagata Japan 15 291 1.4× 11 0.1× 75 0.9× 66 1.0× 3 0.0× 43 503
Satoshi Maruyama Japan 11 162 0.8× 8 0.1× 48 0.6× 55 0.8× 6 0.1× 37 373
Zach Dovey United States 12 405 2.0× 129 1.0× 193 2.3× 127 1.9× 3 0.0× 22 554
Tetsuya Imao Japan 13 187 0.9× 14 0.1× 54 0.6× 58 0.9× 2 0.0× 40 470
Dimitrios Karamanolakis Greece 13 173 0.9× 18 0.1× 38 0.4× 98 1.4× 25 398
Nobuhiko Hyochi Japan 12 211 1.0× 4 0.0× 32 0.4× 37 0.5× 20 0.3× 29 345
R.O. Mirimanoff Switzerland 8 170 0.8× 25 0.2× 55 0.6× 34 0.5× 2 0.0× 27 339
Turki Al‐Hussain Saudi Arabia 10 188 0.9× 17 0.1× 76 0.9× 19 0.3× 2 0.0× 33 344

Countries citing papers authored by M. Ferro

Since Specialization
Citations

This map shows the geographic impact of M. Ferro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ferro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ferro more than expected).

Fields of papers citing papers by M. Ferro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ferro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ferro. The network helps show where M. Ferro may publish in the future.

Co-authorship network of co-authors of M. Ferro

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ferro. A scholar is included among the top collaborators of M. Ferro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ferro. M. Ferro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luzzago, Stefano, Michele Catellani, Francesco Alessandro Mistretta, et al.. (2018). Multiparametric magnetic resonance of the prostate second opinion may reduce the number of unnecessary biopsies: A single center experience. European Urology Supplements. 17(2). e894–e894. 1 indexed citations
2.
Ferro, M., Daniela Terracciano, Alfonso Mariño, et al.. (2011). Prostate health index (PHI) is able to discriminate benign and precancerous conditions from prostate cancer. 31. 1916–1917. 1 indexed citations
3.
Ferro, M., et al.. (2007). The treatment of chyluria secondary to advanced carcinoma of the prostate. Prostate Cancer and Prostatic Diseases. 11(1). 102–105. 3 indexed citations
4.
Ferro, José M., et al.. (2002). Long-Term Prognosis of Cerebral Vein and Dural Sinus Thrombosis. Cerebrovascular Diseases. 13(4). 272–278. 129 indexed citations
5.
Ferro, M., et al.. (1997). Duodenal stenosis from intramural cystic annular pancreas.. PubMed. 43(9). 776–8. 2 indexed citations
6.
Vitali, A, et al.. (1994). Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.. PubMed. 14(4A). 1503–7. 6 indexed citations
7.
Oliveira, Catarina R., et al.. (1993). Glutamate Dehydrogenase Deficiency in Machado-Joseph Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 20(2). 147–150. 4 indexed citations
8.
Perachino, Massimo, et al.. (1993). Does TransurethralThermotherapy Induce aLong-Term Alpha Blockade?. European Urology. 23(2). 299–301. 42 indexed citations
9.
Ferro, M.. (1991). Use of Intravenous Stilbestrol Diphosphate in Patients with Prostatic Carcinoma Refractory to Conventional Hormonal Manipulation. Urologic Clinics of North America. 18(1). 139–143. 20 indexed citations
10.
Stower, Michael J., et al.. (1990). Quantification of prostatic cancer metastaticdisease using prostate-specific antigen. Urology. 35(6). 483–486. 10 indexed citations
11.
Ferro, M., et al.. (1989). Testing the Chemosensitivity of Renal Carcinoma in vitro. British Journal of Urology. 64(1). 25–29. 1 indexed citations
12.
Ferro, M., David Gillatt, M O Symes, & Patrick J. Smith. (1989). High-dose intravenous estrogen therapy in advanced prostatic carcinoma. Urology. 34(3). 134–138. 46 indexed citations
13.
Ferro, M., et al.. (1988). Effect of Stilboestrol and Testosterone on the Incorporation of 75 Selenomethionine by Prostatic Carcinoma Cells. British Journal of Urology. 62(2). 166–172. 12 indexed citations
14.
Ferro, M., et al.. (1988). Periurethral granuloma: Unusual complication of teflon periurethral injection. Urology. 31(5). 422–423. 37 indexed citations
15.
Cunha, Luı́s, Maria Alzira Pimenta Dinis, Catarina R. Oliveira, et al.. (1988). Dominantly Inherited Ataxias in Portugal. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 15(4). 397–401. 4 indexed citations
16.
Ferro, M., et al.. (1988). Tumour Markers in Prostatic Carcinoma. A Comparison of Prostate-Specific Antigen With Acid Phosphatase. The Journal of Urology. 139(3). 659–660. 7 indexed citations
17.
Hershman, M J, et al.. (1987). The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.. PubMed. 53(12). 691–4. 4 indexed citations
18.
Phillips, M. E., et al.. (1987). Intranuclear Androgen Receptor Deployment and Protooncogene Expression in Human Diseased Prostate. Urologia Internationalis. 42(2). 115–119. 16 indexed citations
19.
Ferro, M., et al.. (1987). Tumour Markers in Prostatic Carcinoma. A Comparison of Prostate‐specific Antigen with Acid Phosphatase. British Journal of Urology. 60(1). 69–73. 87 indexed citations
20.
Calvo, Felipe A., et al.. (1981). [Relationship between pancreatic cancer and chronic pancreatitis].. PubMed. 72(46). 3119–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026